Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > ATRC AtriCure > Detailed Quotes

ATRC AtriCure

38.930
+0.370+0.96%
Close 09/26 16:00 ET
High
39.665
Open
38.290
Turnover
7.24M
Low
38.020
Pre Close
38.560
Volume
185.38K
Market Cap
1.81B
P/E(TTM)
33.27
52wk High
89.180
Shares
46.42M
P/E(Static)
35.72
52wk Low
32.835
Float Cap
1.76B
Bid/Ask %
0.00%
Historical High
89.180
Shs Float
45.12M
Volume Ratio
0.59
Historical Low
1.000
Dividend TTM
--
Div Yield TTM
1000
P/B
3.96
Dividend LFY
--
Div Yield LFY
2568.71%
Turnover Ratio
0.41%
Amplitude
4.27%
Avg Price
39.040
Lot Size
1
Float Cap
1.76B
Bid/Ask %
0.00%
Historical High
89.180
Shs Float
45.12M
Volume Ratio
0.59
Historical Low
1.000
Dividend TTM
--
P/B
3.96
Dividend LFY
--
Turnover Ratio
0.41%
Amplitude
4.27%
Avg Price
39.040
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
AtriCure, Inc. engages in the development, manufacture, and sale of devices designed primarily for the surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded by Michael D. Hooven on October 31, 2000 and is headquartered in Mason, OH.
CEO: --
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...